As of September 2026, pramlintide is an approved medicine in the US. The FDA approved it in 2005 as Symlin, for use alongside mealtime insulin in adults with diabetes. It is not currently marketed in the EU. If a vial sold as pramlintide reached you outside a pharmacy, the approval trials did not test it, and you cannot tell from the outside what it holds.
Get an email when the pramlintide record changes.
What is pramlintide?
Pramlintide is a synthetic, slightly modified version of amylin, a hormone the pancreas releases alongside insulin. Amylin Pharmaceuticals developed it as an add-on treatment, because people with diabetes are short of amylin. The FDA approved it in 2005 as Symlin.
Does pramlintide work?
For its approved use, the FDA reviewed the trials and approved it. That use is alongside mealtime insulin, in adults with type 1 or type 2 diabetes who still need better blood sugar control.
What we found. 5+ completed randomized trials counted on the record. 3 study rows listed below, so the number shows with a plus sign until every trial is listed.
| Study | Tested in | Status | What it shows |
|---|---|---|---|
| Symlin approval trials (Phase 3) | People | Completed. Symlin was approved in 2005 | Trials in type 1 and type 2 diabetes supported approval as an add-on to mealtime insulin |
| Add-on pramlintide in type 1 diabetes (HbA1c study) | People | Published 2005 | Lower HbA1c, a blood sugar measure, with no added weight gain. The record notes a risk of low blood sugar |
| Placebo-controlled trial with intensive insulin therapy | People | Published 2006 | A blood sugar benefit from add-on pramlintide over insulin alone |
Is pramlintide safe?
The record names two main concerns. The first is a significant risk of severe low blood sugar when it is combined with insulin. The second is stomach and gut side effects. Recent real-world and long-term outcome data are limited, because most of the main evidence dates to the mid-2000s. All of this is the record of Symlin. It says nothing about a vial from any other source, which the vial section covers.
Is pramlintide legal?
- United States
- Approved by the FDA in 2005 as Symlin, as an add-on to mealtime insulin in type 1 or type 2 diabetes.
- European Union
- Not currently marketed in the EU. The record does not say whether the EMA ever approved it.
- Sport
- Not named on WADA's list. That is not clearance.
Not medical advice. Approval and sport status as of . Medical disclaimer
What is in a vial sold as pramlintide?
The approval trials above tested Symlin, the maker's product. This record holds no sign that pramlintide is sold outside pharmacies. If a vial reached you by another road, none of those trials tested it, and the checklist lists what to ask the seller.
What don't we know?
- What recent real-world use shows. Most of the main evidence dates to the mid-2000s.
- What long-term outcomes look like. Those data are limited.
- Whether pramlintide plus insulin does better than today's automated insulin delivery systems.
- What is in any vial that did not come from a pharmacy.
The other side
Symlin comes with a prescription and a doctor's care, and the record describes a long clinical trial history. It is still an approved drug in the US. It is used less often now that simpler, newer diabetes treatments are available.
What would change this record?
- A modern controlled trial comparing pramlintide plus insulin with current automated insulin delivery systems.
Three questions to ask next
- What does 'research use only' actually mean?
- How can you tell if a peptide vendor is legitimate?
- How do you read a certificate of analysis?
Ask better questions.
More questions about pramlintide
Is Symlin the same as pramlintide?
- Yes. Symlin is the brand name for pramlintide.
What is pramlintide approved for?
- In the US, for use alongside mealtime insulin in adults with type 1 or type 2 diabetes who still need better blood sugar control. The FDA approved it in 2005.
Is pramlintide approved in Europe?
- The record does not say. It says only that pramlintide is not currently marketed in the EU.
Is pramlintide the same as cagrilintide?
- No. Both are lab-made versions of amylin. The FDA approved pramlintide in 2005 as Symlin. Cagrilintide is not approved by the FDA or the EMA.
Is pramlintide banned in sport?
- It is not named on WADA's list. That is not clearance. This record links no WADA document. If you compete, check the current List.
Record checked on . Each source shows the date it was checked.
In the same group
- RetatrutideGrade B5+ completed randomized trials
- Semaglutide (Ozempic, Wegovy, Rybelsus)Grade A12+ completed randomized trials
- SurvodutideGrade B4 completed randomized trials
- Tirzepatide (Mounjaro, Zepbound)Grade A8+ completed randomized trials
- AOD-9604Grade B2 completed randomized trials
- CagrilintideGrade B3 completed randomized trials